Serum levels of immunoglobulin M‐free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis‐associated hepatocellular carcinoma-Reference-Cited by-同舟云学术

Serum levels of immunoglobulin M‐free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis‐associated hepatocellular carcinoma

Published:2022-08-28 Issue:12 Volume:52 Page:998-1008
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Okanoue Takeshi¹^ORCID,Yamaguchi Kanji²,Shima Toshihide¹,Mitsumoto Yasuhide¹,Mizuno Masayuki¹,Katayama Takayuki¹,Seko Yuya²,Moriguchi Michihisa²,Umemura Atsushi³,Itoh Yoshito²,Miyazaki Toru⁴⁵⁶

Affiliation:

1. Department of Gastroenterology and Hepatology Saiseikai Suita Hospital Osaka Japan

2. Molecular Gastroenterology and Hepatology Kyoto Prefectural University of Medicine Kyoto Japan

3. Department of Pharmacology Kyoto Prefectural University of Medicine Kyoto Japan

4. The Institute for AIM Medicine TWINS Tokyo Japan

5. LEAP Japan Agency for Medical Research and Development Tokyo Japan

6. Laboratoire d’ImmunoRhumatologie Moléculaire Plateforme GENOMAX Institut National de la Santé et de la Recherche Médicale UMR_S 1109 Faculté de Médecine Fédération Hospitalo‐Universitaire OMICARE Fédération de Médecine Translationnelle de Strasbourg Laboratory of Excellence TRANSPLANTEX Université de Strasbourg Strasbourg France

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13826

Reference42 articles.

1. Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

2. Impact of obesity on risk of cancer

3. Prevalence and predictors of obesity-related cancers among racial/ethnic groups with metabolic syndrome

4. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD;Current Obesity Reports;2024-05-29

2. CD5L as a promising biological therapeutic for treating sepsis;Nature Communications;2024-05-15

3. AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions;Journal of Autoimmunity;2024-01

4. Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis;Expert Review of Gastroenterology & Hepatology;2023-11-02

5. Artificial intelligence/neural network system that accurately diagnoses hepatocellular carcinoma in nonalcoholic steatohepatitis;Hepatology Research;2023-09-07